These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 12696062

  • 1. Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells.
    Florl AR, Schulz WA.
    Genes Chromosomes Cancer; 2003 Jun; 37(2):141-8. PubMed ID: 12696062
    [Abstract] [Full Text] [Related]

  • 2. Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines.
    Raschke S, Balz V, Efferth T, Schulz WA, Florl AR.
    Genes Chromosomes Cancer; 2005 Jan; 42(1):58-67. PubMed ID: 15495191
    [Abstract] [Full Text] [Related]

  • 3. Molecular processes of chromosome 9p21 deletions in human cancers.
    Sasaki S, Kitagawa Y, Sekido Y, Minna JD, Kuwano H, Yokota J, Kohno T.
    Oncogene; 2003 Jun 12; 22(24):3792-8. PubMed ID: 12802286
    [Abstract] [Full Text] [Related]

  • 4. Molecular processes of chromosome 9p21 deletions causing inactivation of the p16 tumor suppressor gene in human cancer: deduction from structural analysis of breakpoints for deletions.
    Kohno T, Yokota J.
    DNA Repair (Amst); 2006 Sep 08; 5(9-10):1273-81. PubMed ID: 16931177
    [Abstract] [Full Text] [Related]

  • 5. Two regions of homozygous deletion clusters at chromosome band 9p21 in human lung cancer.
    Hamada K, Kohno T, Takahashi M, Yamazaki M, Yamazaki M, Tashiro H, Sugawara C, Ohwada S, Sekido Y, Minna JD, Yokota J.
    Genes Chromosomes Cancer; 2000 Mar 08; 27(3):308-18. PubMed ID: 10679921
    [Abstract] [Full Text] [Related]

  • 6. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.
    Berggren P, Kumar R, Sakano S, Hemminki L, Wada T, Steineck G, Adolfsson J, Larsson P, Norming U, Wijkström H, Hemminki K.
    Clin Cancer Res; 2003 Jan 08; 9(1):235-42. PubMed ID: 12538475
    [Abstract] [Full Text] [Related]

  • 7. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr 08; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 8. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
    Cairns P, Tokino K, Eby Y, Sidransky D.
    Cancer Res; 1995 Jan 15; 55(2):224-7. PubMed ID: 7812948
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancer.
    Berggren de Verdier PJ, Kumar R, Adolfsson J, Larsson P, Norming U, Onelöv E, Wijkström H, Steineck G, Hemminki K.
    Scand J Urol Nephrol; 2006 Jan 15; 40(5):363-9. PubMed ID: 17060081
    [Abstract] [Full Text] [Related]

  • 11. Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer.
    Tsutsumi M, Tsai YC, Gonzalgo ML, Nichols PW, Jones PA.
    Oncogene; 1998 Dec 10; 17(23):3021-7. PubMed ID: 9881704
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family.
    Knappskog S, Geisler J, Arnesen T, Lillehaug JR, Lønning PE.
    Genes Chromosomes Cancer; 2006 Dec 10; 45(12):1155-63. PubMed ID: 17001621
    [Abstract] [Full Text] [Related]

  • 14. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.
    Balázs M, Carroll P, Kerschmann R, Sauter G, Waldman FM.
    Genes Chromosomes Cancer; 1997 Jun 10; 19(2):84-9. PubMed ID: 9171998
    [Abstract] [Full Text] [Related]

  • 15. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
    Toomes C, Jackson A, Maguire K, Wood J, Gollin S, Ishwad C, Paterson I, Prime S, Parkinson K, Bell S, Woods G, Markham A, Oliver R, Woodward R, Sloan P, Dixon M, Read A, Thakker N.
    Genes Chromosomes Cancer; 2003 Jun 10; 37(2):132-40. PubMed ID: 12696061
    [Abstract] [Full Text] [Related]

  • 16. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
    Bertin R, Acquaviva C, Mirebeau D, Guidal-Giroux C, Vilmer E, Cavé H.
    Genes Chromosomes Cancer; 2003 May 10; 37(1):44-57. PubMed ID: 12661005
    [Abstract] [Full Text] [Related]

  • 17. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
    Weber RG, Hoischen A, Ehrler M, Zipper P, Kaulich K, Blaschke B, Becker AJ, Weber-Mangal S, Jauch A, Radlwimmer B, Schramm J, Wiestler OD, Lichter P, Reifenberger G.
    Oncogene; 2007 Feb 15; 26(7):1088-97. PubMed ID: 16909113
    [Abstract] [Full Text] [Related]

  • 18. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS, Farrington DL, Mayhugh BM, Qin Y, Temples T, Comerford K, Chakrabarti R, Zainabadi K, Redpath JL, Stanbridge EJ, Srivatsan ES.
    Genes Chromosomes Cancer; 2004 Apr 15; 39(4):277-87. PubMed ID: 14978789
    [Abstract] [Full Text] [Related]

  • 19. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.
    Sato M, Takahashi K, Nagayama K, Arai Y, Ito N, Okada M, Minna JD, Yokota J, Kohno T.
    Genes Chromosomes Cancer; 2005 Dec 15; 44(4):405-14. PubMed ID: 16114034
    [Abstract] [Full Text] [Related]

  • 20. Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA.
    Devlin J, Keen AJ, Knowles MA.
    Oncogene; 1994 Sep 15; 9(9):2757-60. PubMed ID: 8058343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.